BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2735767
Number of visits today
438
Number of downloads
2006353
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Li W, Wang X, Liu T, Zhang Q, Cao J, Jiang Y, Sun Q, Li C, Wang W, Wang Y. Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy. Front Cell Dev Biol 2022;10:813370. [DOI: 10.3389/fcell.2022.813370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kawano I, Adamcova M. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1055911] [Reference Citation Analysis]
2 Khairnar SI, Kulkarni YA, Singh K. Cardiotoxicity linked to anticancer agents and cardioprotective strategy. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01411-4] [Reference Citation Analysis]
3 Ling G, Wang X, Tan N, Cao J, Li W, Zhang Y, Jiang J, Sun Q, Jiang Y, Wang W, Wang Y, Camara A. Mechanisms and Drug Intervention for Doxorubicin-Induced Cardiotoxicity Based on Mitochondrial Bioenergetics. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/7176282] [Reference Citation Analysis]
4 Ji Y, Jin D, Qi J, Wang X, Zhang C, An P, Luo Y, Luo J. Fucoidan Protects against Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Preventing Mitochondrial Function Injury. IJMS 2022;23:10685. [DOI: 10.3390/ijms231810685] [Reference Citation Analysis]
5 Li W, Zhang Y, Wang X, Cao J, Qian W, Ling G, Tan N, Jiang J, Sun Q, Li C, Wang W, Wang Y, Jakovljevic V. Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/4344677] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345